Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1A-116 是 Rac1的抑制剂,对几种类型的癌症具有抗肿瘤和抗转移作用,如乳腺癌。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 497 | 现货 | ||
5 mg | ¥ 1,160 | 现货 | ||
10 mg | ¥ 1,890 | 现货 | ||
25 mg | ¥ 3,380 | 现货 | ||
50 mg | ¥ 4,850 | 现货 | ||
100 mg | ¥ 6,730 | 现货 | ||
500 mg | ¥ 13,500 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,280 | 现货 |
产品描述 | 1A-116 is a specific Rac1 inhibitor. |
靶点活性 | Antiproliferative:4 µM(F3II cell) |
体外活性 | 1A-116 shows lesser effect on MCF7::pcDNA.3 cells than on MCF7::C1199 cells. 1A-116 treatment decreases phospho-PAK1 levels in a time-dependent manner. The presence of 1A-116 reverts the PAK1 phosphorylation induced by 4-hydroxytamoxifen (Tam). The presence of 1A-116 also effectively reverts Rac1-PAK1-mediated estrogen receptor (ER) phosphorylation at Ser305[1]. 1A-116 shows a significant increase in antiproliferative activity on F3II cells, showing an IC50 value of 4 μM. A-116 also dramatically impairs Rac1 activation at low micromolar range (1 μM)[2]. |
体内活性 | Daily treatment of mice with compound 1A-116 at 3mg/kg body weight/day reduces about 60% the formation of total metastatic lung colonies. A significant antitumor activity is obtained for macronodules (more than 1 mm in diameter) by treatment with 1A-116 in this highly aggressive breast cancer model. The treatment with 1A-116 reduces the total lung weight compare to the control group, leading to a total weight similar to the average pulmonary weight of Balb/c mice[2]. |
分子量 | 307.31 |
分子式 | C16H16F3N3 |
CAS No. | 1430208-73-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (325.40 mM), Sonication is recommended.
H2O: < 0.1 mg/mL (insoluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.254 mL | 16.2702 mL | 32.5404 mL | 81.3511 mL |
5 mM | 0.6508 mL | 3.254 mL | 6.5081 mL | 16.2702 mL | |
10 mM | 0.3254 mL | 1.627 mL | 3.254 mL | 8.1351 mL | |
20 mM | 0.1627 mL | 0.8135 mL | 1.627 mL | 4.0676 mL | |
50 mM | 0.0651 mL | 0.3254 mL | 0.6508 mL | 1.627 mL | |
100 mM | 0.0325 mL | 0.1627 mL | 0.3254 mL | 0.8135 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
1A-116 1430208-73-3 Cell Cycle/Checkpoint Rho TIAM1 inhibit 1A 116 Ras Rho GTPases EGF Apoptosis 1A116 circadian rhythms Inhibitor inhibitor